FDA grants RPDD to ReviR’s RTX-117 for CMT
ReviR Therapeutics has received a rare paediatric disease designation (RPDD) from the US Food and Drug Administration (FDA) for RTX-117,…
All articles by Salong Debbarma
Salong Debbarma
-
-
ViiV Healthcare’s Tivicay PD gains FDA approval for paediatric HIV therapy
The US Food and Drug Administration (FDA) has approved ViiV Healthcare’s Tivicay PD (dolutegravir), for use with other antiretroviral agents…
-
Jazz secures FDA approval for Ziihera in advanced HER2+ GEA
The US Food and Drug Administration (FDA) has approved two Jazz Pharmaceuticals regimens containing Ziihera (zanidatamab-hrii) for the first-line treatment…
-
McKesson to acquire Precision Medicine Group for $2.25bn
US-based healthcare services provider McKesson has agreed to buy Precision Medicine Group for $2.25bn. McKesson believes that the deal will…
-
Lundbeck’s asedebart receives EC orphan designation in Cushing’s syndrome
The European Commission (EC) has granted orphan designation to Lundbeck’s investigational monoclonal antibody asedebart (Lu AG13909) for the treatment of…
-
FDA places clinical hold on Regenxbio’s RGX-121 in MPS II trial
REGENXBIO has reported that the US Food and Drug Administration (FDA) has placed a clinical hold on its investigational gene…
-
Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
Takeda has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Orzeyful (oveporexton) to treat narcolepsy type…
-
WellSpan and Johns Hopkins renew partnership for advanced cancer care access
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical…
-
Charles River and MVC to develop enterovirus vaccine
Charles River Laboratories International and Medigen Vaccine Biologics (MVC) have entered a collaboration to support the characterisation along with validation…
-
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
Ultragenyx Pharmaceutical has received accelerated approval from the US Food and Drug Administration (FDA) for its gene therapy, Genglycos (pariglasgene…